May 26, 2021 / 12:00PM GMT
Christian Lawrence Hogg - HUTCHMED(China)Limited-Former CEO&Executive Director
Okay. Thank you very much for attending today the HUTCHMED company update. We're going to cover R&D. We're going to cover commercial updates. And most importantly, we'll also cover the 10 abstracts that have recently been published for ASCO, covering many of our assets.
So if you could move to the agenda, the agenda today is quite varied, a varied update. We will have Dr. Wei-Guo Su, our Chief Scientific Officer; and Dr. Marek Kania, our Head of International and Chief Medical Officer in international, cover our pipeline, our development pipeline. And Wei-Guo will also give more color on our early programs, our discovery strategy. I will touch on the market potential of various of our assets. And that will be followed by Chen Hong to talk about China commercial and Tom Held, the U.S. So Chen Hong is our Chief Commercial Officer in China; and Tom Held is our Senior VP of Commercial in the United States, building our team. We'll then briefly touch
HUTCHMED (China) Ltd virtual investor update Call Transcript
Mar 04, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers